• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

住院退伍军人感染阿尔法、德尔塔和奥密克戎 SARS-CoV-2 变异株的炎症生物标志物存在差异。

Inflammatory Biomarkers Differ among Hospitalized Veterans Infected with Alpha, Delta, and Omicron SARS-CoV-2 Variants.

机构信息

VA's Health Services Research and Development Service (HSR&D), Center for Innovations in Quality, Effectiveness, and Safety, Michael E. DeBakey VA Medical Center, Houston, TX 77030, USA.

Big Data Scientist Training Enhancement Program, VA Office of Research and Development, Washington, DC 20420, USA.

出版信息

Int J Environ Res Public Health. 2023 Feb 8;20(4):2987. doi: 10.3390/ijerph20042987.

DOI:10.3390/ijerph20042987
PMID:36833680
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9959816/
Abstract

Mortality due to COVID-19 has been correlated with laboratory markers of inflammation, such as C-reactive protein (CRP). The lower mortality during Omicron variant infections could be explained by variant-specific immune responses or host factors, such as vaccination status. We hypothesized that infections due to Omicron variant cause less inflammation compared to Alpha and Delta, correlating with lower mortality. This was a retrospective cohort study of veterans hospitalized for COVID-19 at the Veterans Health Administration. We compared inflammatory markers among patients hospitalized during Omicron infection with those of Alpha and Delta. We reported the adjusted odds ratio (aOR) of the first laboratory results during hospitalization and in-hospital mortality, stratified by vaccination status. Of 2,075,564 Veterans tested for COVID-19, 29,075 Veterans met the criteria: Alpha (45.1%), Delta (23.9%), Omicron (31.0%). Odds of abnormal CRP in Delta (aOR = 1.85, 95% CI:1.64-2.09) and Alpha (aOR = 1.94, 95% CI:1.75-2.15) were significantly higher compared to Omicron. The same trend was observed for Ferritin, Alanine aminotransferase, Aspartate aminotransferase, Lactate dehydrogenase, and Albumin. The mortality in Delta (aOR = 1.92, 95% CI:1.73-2.12) and Alpha (aOR = 1.68, 95% CI:1.47-1.91) were higher than Omicron. The results remained significant after stratifying the outcomes based on vaccination status. Veterans infected with Omicron showed milder inflammatory responses and lower mortality than other variants.

摘要

COVID-19 导致的死亡率与炎症的实验室标志物有关,如 C 反应蛋白 (CRP)。Omicron 变体感染期间较低的死亡率可以用变体特异性免疫反应或宿主因素来解释,例如疫苗接种状态。我们假设与 Alpha 和 Delta 相比,Omicron 变体感染引起的炎症反应较轻,这与较低的死亡率有关。这是退伍军人事务部 (VA) 因 COVID-19 住院的退伍军人的回顾性队列研究。我们比较了在 Omicron 感染期间住院患者与 Alpha 和 Delta 患者的炎症标志物。我们报告了在住院期间和住院期间死亡率的第一份实验室结果的调整比值比 (aOR),并按疫苗接种状态进行分层。在接受 COVID-19 检测的 2075564 名退伍军人中,有 29075 名退伍军人符合标准:Alpha (45.1%)、Delta (23.9%)、Omicron (31.0%)。Delta (aOR = 1.85, 95%CI:1.64-2.09) 和 Alpha (aOR = 1.94, 95%CI:1.75-2.15) 的异常 CRP 几率明显高于 Omicron。Ferritin、丙氨酸氨基转移酶、天冬氨酸氨基转移酶、乳酸脱氢酶和白蛋白也出现了同样的趋势。Delta (aOR = 1.92, 95%CI:1.73-2.12) 和 Alpha (aOR = 1.68, 95%CI:1.47-1.91) 的死亡率均高于 Omicron。根据疫苗接种状态对结果进行分层后,结果仍然显著。感染 Omicron 的退伍军人的炎症反应较轻,死亡率低于其他变体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dd9/9959816/216520325f6a/ijerph-20-02987-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dd9/9959816/ff20b2b49846/ijerph-20-02987-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dd9/9959816/216520325f6a/ijerph-20-02987-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dd9/9959816/ff20b2b49846/ijerph-20-02987-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dd9/9959816/216520325f6a/ijerph-20-02987-g001.jpg

相似文献

1
Inflammatory Biomarkers Differ among Hospitalized Veterans Infected with Alpha, Delta, and Omicron SARS-CoV-2 Variants.住院退伍军人感染阿尔法、德尔塔和奥密克戎 SARS-CoV-2 变异株的炎症生物标志物存在差异。
Int J Environ Res Public Health. 2023 Feb 8;20(4):2987. doi: 10.3390/ijerph20042987.
2
Adverse outcomes of SARS-CoV-2 infection with delta and omicron variants in vaccinated versus unvaccinated US veterans: retrospective cohort study.接种疫苗与未接种疫苗的美国退伍军人中感染 SARS-CoV-2 的德尔塔和奥密克戎变异株的不良结局:回顾性队列研究。
BMJ. 2023 May 23;381:e074521. doi: 10.1136/bmj-2022-074521.
3
Clinical characteristics and severity markers in hospitalized COVID-19 patients from western Mexico: a comparative analysis of Delta and Omicron variants.墨西哥西部住院COVID-19患者的临床特征和严重程度标志物:Delta和Omicron变异株的比较分析
Front Public Health. 2024 Aug 30;12:1425372. doi: 10.3389/fpubh.2024.1425372. eCollection 2024.
4
Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.疫苗对 Alpha、Delta 或奥密克戎变异株引起的 SARS-CoV-2 感染或 COVID-19 住院的有效性:一项全国性丹麦队列研究。
PLoS Med. 2022 Sep 1;19(9):e1003992. doi: 10.1371/journal.pmed.1003992. eCollection 2022 Sep.
5
Comparative severity of COVID-19 cases caused by Alpha, Delta or Omicron SARS-CoV-2 variants and its association with vaccination.比较 Alpha、Delta 或 Omicron SARS-CoV-2 变异株引起的 COVID-19 病例的严重程度及其与疫苗接种的关系。
Enferm Infecc Microbiol Clin (Engl Ed). 2024 Apr;42(4):187-194. doi: 10.1016/j.eimce.2022.11.021. Epub 2023 Feb 1.
6
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.2021 年 7 月 15 日至 9 月 23 日和 2021 年 12 月 21 日至 2022 年 1 月 27 日期间,加利福尼亚州一家医院因实验室确诊的 SARS-CoV-2 感染住院的成年人的临床特征和结局,期间 B.1.617.2(德尔塔)和 B.1.1.529(奥密克戎)变异株占主导地位。
MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):217-223. doi: 10.15585/mmwr.mm7106e2.
7
Clinical Characteristics and Outcomes of Children With SARS-CoV-2 Infection During the Delta and Omicron Variant-Dominant Periods in Korea.韩国德尔塔和奥密克戎变异株流行期间儿童感染 SARS-CoV-2 的临床特征和结局。
J Korean Med Sci. 2023 Mar 6;38(9):e65. doi: 10.3346/jkms.2023.38.e65.
8
Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.mRNA COVID-19 疫苗 3 剂接种与 SARS-CoV-2 奥密克戎和德尔塔变异株引起的有症状感染之间的关联。
JAMA. 2022 Feb 15;327(7):639-651. doi: 10.1001/jama.2022.0470.
9
Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.疫苗对 Alpha、Delta 或奥密克戎变异株流行期间 SARS-CoV-2 再感染的有效性:一项丹麦全国性研究。
PLoS Med. 2022 Nov 22;19(11):e1004037. doi: 10.1371/journal.pmed.1004037. eCollection 2022 Nov.
10
Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.与未接种疫苗的患者相比,使用主要生物标志物比较感染 SARS-CoV-2 Delta 或 Omicron VOC 患者的疾病严重程度和同源疫苗接种效果。
J Med Virol. 2022 Dec;94(12):5867-5876. doi: 10.1002/jmv.28098. Epub 2022 Sep 9.

引用本文的文献

1
Dual inflammation in schizophrenia infected with COVID-19: Impact on cognitive function.感染新冠病毒的精神分裂症患者的双重炎症:对认知功能的影响。
Brain Behav Immun Health. 2025 Apr 26;46:100997. doi: 10.1016/j.bbih.2025.100997. eCollection 2025 Jul.
2
Ensitrelvir in Hospitalized Patients with SARS-CoV-2 During the Omicron Epidemic: A Single-Center Observational Study.奥密克戎疫情期间住院的新型冠状病毒肺炎患者使用恩西他韦的单中心观察性研究
Infect Dis Ther. 2025 Apr 19. doi: 10.1007/s40121-025-01156-9.
3
Differences in the inflammatory response and outcome among hospitalized patients during different waves of the COVID-19 pandemic.

本文引用的文献

1
Risk of severe clinical outcomes among persons with SARS-CoV-2 infection with differing levels of vaccination during widespread Omicron (B.1.1.529) and Delta (B.1.617.2) variant circulation in Northern California: A retrospective cohort study.在加利福尼亚州北部广泛流行奥密克戎(B.1.1.529)和德尔塔(B.1.617.2)变种期间,不同疫苗接种水平的新冠病毒感染者出现严重临床结局的风险:一项回顾性队列研究
Lancet Reg Health Am. 2022 Aug;12:100297. doi: 10.1016/j.lana.2022.100297. Epub 2022 Jun 16.
2
Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5.严重急性呼吸综合征冠状病毒2型奥密克戎亚变体BA.2.12.1、BA.4和BA.5的中和逃逸
N Engl J Med. 2022 Jul 7;387(1):86-88. doi: 10.1056/NEJMc2206576. Epub 2022 Jun 22.
3
新冠疫情不同波次期间住院患者炎症反应及预后的差异。
Front Immunol. 2025 Mar 27;16:1545181. doi: 10.3389/fimmu.2025.1545181. eCollection 2025.
4
Construction and validation of a risk model of proteinuria in patients with omicron COVID-19: retrospective cohort study.奥密克戎 COVID-19 患者蛋白尿风险模型的构建与验证:回顾性队列研究。
Ren Fail. 2024 Dec;46(2):2365979. doi: 10.1080/0886022X.2024.2365979. Epub 2024 Aug 6.
5
The Saga of COVID-19 in Chronic Lung Disease: History Repeats Itself.慢性肺病中的新冠传奇:历史重演。
Ann Am Thorac Soc. 2024 Jul;21(7):1001-1002. doi: 10.1513/AnnalsATS.202404-442ED.
6
Relationship between the Viral Load in Patients with Different COVID-19 Severities and SARS-CoV-2 Variants.不同严重程度的新型冠状病毒肺炎患者病毒载量与严重急性呼吸综合征冠状病毒2变异株之间的关系
Microorganisms. 2024 Feb 20;12(3):428. doi: 10.3390/microorganisms12030428.
7
Incidence of Immune Checkpoint Inhibitor-Induced Myocarditis During the COVID-19 Pandemic.新冠疫情期间免疫检查点抑制剂诱发心肌炎的发病率
J Am Heart Assoc. 2024 Mar 19;13(6):e032667. doi: 10.1161/JAHA.123.032667. Epub 2024 Mar 18.
8
Immunohematologic Biomarkers in COVID-19: Insights into Pathogenesis, Prognosis, and Prevention.COVID-19中的免疫血液生物标志物:对发病机制、预后和预防的见解
Pathog Immun. 2023 Jun 26;8(1):17-50. doi: 10.20411/pai.v8i1.572. eCollection 2023.
9
Effects of Different Types of Recombinant SARS-CoV-2 Spike Protein on Circulating Monocytes' Structure.不同类型的 SARS-CoV-2 刺突蛋白对循环单核细胞结构的影响。
Int J Mol Sci. 2023 May 27;24(11):9373. doi: 10.3390/ijms24119373.
10
Blood Biomarkers from the Emergency Department Disclose Severe Omicron COVID-19-Associated Outcomes.急诊科血液生物标志物揭示了与严重奥密克戎新冠病毒病相关的结局。
Microorganisms. 2023 Apr 2;11(4):925. doi: 10.3390/microorganisms11040925.
Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections.
既往感染和疫苗接种对奥密克戎感染症状的影响。
N Engl J Med. 2022 Jul 7;387(1):21-34. doi: 10.1056/NEJMoa2203965. Epub 2022 Jun 15.
4
Severe hospital events following symptomatic infection with Sars-CoV-2 Omicron and Delta variants in France, December 2021-January 2022: A retrospective, population-based, matched cohort study.2021年12月至2022年1月法国出现症状性感染新冠病毒奥密克戎和德尔塔变异株后的严重住院事件:一项基于人群的回顾性配对队列研究。
EClinicalMedicine. 2022 Jun;48:101455. doi: 10.1016/j.eclinm.2022.101455. Epub 2022 May 20.
5
Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study.南非奥密克戎变异株流行期间住院患者的 COVID-19 临床严重程度:一项回顾性观察研究。
Lancet Glob Health. 2022 Jul;10(7):e961-e969. doi: 10.1016/S2214-109X(22)00114-0. Epub 2022 May 18.
6
Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study.英格兰长期护理机构居民感染 SARS-CoV-2 奥密克戎的结果(VIVALDI):一项前瞻性队列研究。
Lancet Healthy Longev. 2022 May;3(5):e347-e355. doi: 10.1016/S2666-7568(22)00093-9. Epub 2022 May 4.
7
Omicron infection milder in nursing home residents.养老院居民感染奥密克戎毒株的症状较轻。
Lancet Healthy Longev. 2022 May;3(5):e314-e315. doi: 10.1016/S2666-7568(22)00101-5. Epub 2022 May 4.
8
The displacement of the SARS-CoV-2 variant Delta with Omicron: An investigation of hospital admissions and upper respiratory viral loads.德尔塔变异株被奥密克戎取代:对住院和上呼吸道病毒载量的调查。
EBioMedicine. 2022 May;79:104008. doi: 10.1016/j.ebiom.2022.104008. Epub 2022 Apr 20.
9
Comparative genomics, evolutionary epidemiology, and RBD-hACE2 receptor binding pattern in B.1.1.7 (Alpha) and B.1.617.2 (Delta) related to their pandemic response in UK and India.比较基因组学、进化流行病学以及 B.1.1.7(阿尔法)和 B.1.617.2(德尔塔)与它们在英国和印度大流行应对相关的 RBD-hACE2 受体结合模式。
Infect Genet Evol. 2022 Jul;101:105282. doi: 10.1016/j.meegid.2022.105282. Epub 2022 Apr 13.
10
Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study.奥密克戎和德尔塔变异株主导期间感染新型冠状病毒(SARS-CoV-2)个体的症状流行率、持续时间及住院风险:来自ZOE COVID研究的一项前瞻性观察性研究
Lancet. 2022 Apr 23;399(10335):1618-1624. doi: 10.1016/S0140-6736(22)00327-0. Epub 2022 Apr 7.